Literature DB >> 28249899

Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism.

Vivek Kumar Mishra1, Malayannan Subramaniam2, Vijayalakshmi Kari1, Kevin S Pitel2, Simon J Baumgart1, Ryan M Naylor2, Sankari Nagarajan1, Florian Wegwitz1, Volker Ellenrieder3, John R Hawse4, Steven A Johnsen5.   

Abstract

TGFβ-SMAD signaling exerts a contextual effect that suppresses malignant growth early in epithelial tumorigenesis but promotes metastasis at later stages. Longstanding challenges in resolving this functional dichotomy may uncover new strategies to treat advanced carcinomas. The Krüppel-like transcription factor, KLF10, is a pivotal effector of TGFβ/SMAD signaling that mediates antiproliferative effects of TGFβ. In this study, we show how KLF10 opposes the prometastatic effects of TGFβ by limiting its ability to induce epithelial-to-mesenchymal transition (EMT). KLF10 depletion accentuated induction of EMT as assessed by multiple metrics. KLF10 occupied GC-rich sequences in the promoter region of the EMT-promoting transcription factor SLUG/SNAI2, repressing its transcription by recruiting HDAC1 and licensing the removal of activating histone acetylation marks. In clinical specimens of lung adenocarcinoma, low KLF10 expression associated with decreased patient survival, consistent with a pivotal role for KLF10 in distinguishing the antiproliferative versus prometastatic functions of TGFβ. Our results establish that KLF10 functions to suppress TGFβ-induced EMT, establishing a molecular basis for the dichotomy of TGFβ function during tumor progression. Cancer Res; 77(9); 2387-400. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249899      PMCID: PMC5445903          DOI: 10.1158/0008-5472.CAN-16-2589

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation.

Authors:  Tareq Hossan; Sankari Nagarajan; Simon J Baumgart; Wanhua Xie; Roberto Tirado Magallanes; Céline Hernandez; Pierre-Marie Chiaroni; Daniela Indenbirken; Melanie Spitzner; Morgane Thomas-Chollier; Marian Grade; Denis Thieffry; Adam Grundhoff; Florian Wegwitz; Steven A Johnsen
Journal:  Stem Cells       Date:  2016-02-13       Impact factor: 6.277

6.  Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.

Authors:  Ze-Shiang Lin; Hsiao-Chien Chu; Yi-Chen Yen; Brian C Lewis; Ya-Wen Chen
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

8.  Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Ludmila Prudkin; Diane D Liu; Natalie C Ozburn; Menghong Sun; Carmen Behrens; Ximing Tang; Kathlynn C Brown; B Nebiyou Bekele; Cesar Moran; Ignacio I Wistuba
Journal:  Mod Pathol       Date:  2009-03-06       Impact factor: 7.842

9.  IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).

Authors:  Anne Zirkel; Marcell Lederer; Nadine Stöhr; Nikolaos Pazaitis; Stefan Hüttelmaier
Journal:  Nucleic Acids Res       Date:  2013-05-15       Impact factor: 16.971

10.  KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.

Authors:  A Ali; P Zhang; Y Liangfang; S Wenshe; H Wang; X Lin; Y Dai; X-h Feng; R Moses; D Wang; X Li; J Xiao
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

View more
  17 in total

1.  Krüppel-like factor 10 (KLF10) is transactivated by the transcription factor C/EBPβ and involved in early 3T3-L1 preadipocyte differentiation.

Authors:  Yuan Liu; Wan-Qiu Peng; Ying-Ying Guo; Yang Liu; Qi-Qun Tang; Liang Guo
Journal:  J Biol Chem       Date:  2018-07-19       Impact factor: 5.157

2.  DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.

Authors:  Feda H Hamdan; Steven A Johnsen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

3.  SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.

Authors:  Claudio Fenizia; Cinzia Bottino; Silvia Corbetta; Raffaella Fittipaldi; Pamela Floris; Germano Gaudenzi; Silvia Carra; Franco Cotelli; Giovanni Vitale; Giuseppina Caretti
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

4.  Perivascular Fibrosis Is Mediated by a KLF10-IL-9 Signaling Axis in CD4+ T Cells.

Authors:  Rulin Zhuang; Jingshu Chen; Henry S Cheng; Carmel Assa; Anurag Jamaiyar; Arvind K Pandey; Daniel Pérez-Cremades; Bofang Zhang; Aspasia Tzani; Akm Khyrul Wara; Jorge Plutzky; Victor Barrera; Preetida Bhetariya; Richard N Mitchell; Zhongmin Liu; Mark W Feinberg
Journal:  Circ Res       Date:  2022-04-20       Impact factor: 23.213

5.  Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.

Authors:  Vivek Kumar Mishra; Florian Wegwitz; Robyn Laura Kosinsky; Madhobi Sen; Roland Baumgartner; Tanja Wulff; Jens T Siveke; Hans-Ulrich Schildhaus; Zeynab Najafova; Vijayalakshmi Kari; Hella Kohlhof; Elisabeth Hessmann; Steven A Johnsen
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

Review 6.  Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.

Authors:  Yutaro Tsubakihara; Aristidis Moustakas
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

Review 7.  KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.

Authors:  Azra Memon; Woon Kyu Lee
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

Review 8.  Extracellular vesicles in urologic malignancies-Implementations for future cancer care.

Authors:  Zhangsong Wu; Zhiqiang Zhang; Wuchao Xia; Jiajia Cai; Yuqing Li; Song Wu
Journal:  Cell Prolif       Date:  2019-08-30       Impact factor: 6.831

9.  MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10.

Authors:  Murong You; Liang Zhang; Xiaoxiang Zhang; Yang Fu; Xieping Dong
Journal:  Clin Interv Aging       Date:  2021-01-11       Impact factor: 4.458

10.  Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer.

Authors:  Qing Song; Liu Yang; Zhifen Han; Xinnan Wu; Ruixiao Li; Lihong Zhou; Ningning Liu; Hua Sui; Jianfeng Cai; Yan Wang; Qing Ji; Qi Li
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.